After being rejected by EU regulators but approved in the U.S., UK, and several Middle Eastern countries, Alzheimer’s drug Kisunla added a new market: … Continue reading Australia Only Approved 1 of the 2 New Alzheimer’s ‘Mab’ Drugs: Kisunla